These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1387365)

  • 21. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
    Anderson GL; Judd HL; Kaunitz AM; Barad DH; Beresford SA; Pettinger M; Liu J; McNeeley SG; Lopez AM;
    JAMA; 2003 Oct; 290(13):1739-48. PubMed ID: 14519708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of miltiple primary cancers. IV. Cancers of the female breast and genital organs.
    Schottenfeld D; Berg J
    J Natl Cancer Inst; 1971 Jan; 46(1):161-70. PubMed ID: 5546189
    [No Abstract]   [Full Text] [Related]  

  • 23. [Early diagnosis of cancer and operative gynaecology. First: The effect of screening examinations on the diagnosis and treatment of cancer (author's transl)].
    Kindermann G
    Geburtshilfe Frauenheilkd; 1979 Jan; 39(1):3-13. PubMed ID: 422023
    [No Abstract]   [Full Text] [Related]  

  • 24. Gynecologic cancer: prevention and screening strategies for the 1990s.
    Curtin JP
    Ann N Y Acad Sci; 1994 Dec; 736():140-6. PubMed ID: 7710200
    [No Abstract]   [Full Text] [Related]  

  • 25. Net effect of oral contraceptive use on the risk of cancer in women in the United States.
    Schlesselman JJ
    Obstet Gynecol; 1995 May; 85(5 Pt 1):793-801. PubMed ID: 7724116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors and etiology in gynecologic cancer.
    Einhorn N
    Curr Opin Oncol; 1990 Oct; 2(5):857-63. PubMed ID: 1965695
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary, multiple neoplasms in gynecologic carcinomas].
    Methfessel HD; Methfessel G; Djakitè S
    Zentralbl Gynakol; 1976; 98(7):421-8. PubMed ID: 961197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical criteria of the risk of oncological diseases in women as a basis for prevention of reproductive system diseases].
    Peresun'ko OP; Cheban VI
    Lik Sprava; 2003; (3-4):60-3. PubMed ID: 12889360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive factors and cancers of the breast and genital organs--are the different cancer sites similarly affected?
    Kvåle G; Heuch I; Nilssen S
    Cancer Detect Prev; 1991; 15(5):369-77. PubMed ID: 1751947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of gynecological cancer and survival of patients].
    Merabishvili VM; Bakhidze EV; Laliantsi ÉI; Urmancheeva AF; Krasil'nikov IA
    Vopr Onkol; 2014; 60(3):288-97. PubMed ID: 25033679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The incidence of malignant neoplasms of the female genital organs in East Germany].
    Berndt H; Hendel V
    Zentralbl Gynakol; 1984; 106(3):145-51. PubMed ID: 6702344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative risk of development and active detection of primary multiple endometrial, breast and ovarian cancer.
    Bokhman JB; Maximov SJ
    Eur J Gynaecol Oncol; 1993; 14(2):114-8. PubMed ID: 8500492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
    Zalutskiĭ IV; Vishnevskaia EE; Kurian LM
    Vopr Onkol; 2006; 52(1):74-7. PubMed ID: 16715709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of crude and age-specific incidence rates of breast, ovary, endometrium and cervix cancers in Iran, 2005.
    Arab M; Noghabaei G; Kazemi SN
    Asian Pac J Cancer Prev; 2014; 15(6):2461-4. PubMed ID: 24761847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geographic considerations of endometrial cancer.
    Dunn JE
    Gynecol Oncol; 1974 Aug; 2(2-3):114-21. PubMed ID: 4457397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.
    Michaan N; Gortzak-Uzan L; Grisario D; Laskov I
    Int J Gynaecol Obstet; 2018 Aug; 142(2):176-181. PubMed ID: 29742279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Specifics of individual risks in a group of women with genital neoplasms].
    Matei M; Negură L; Carasevici E; Azoicăi D
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1216-21. PubMed ID: 20191902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gynaecological malignancies in pregnancy: a review.
    Oehler MK; Wain GV; Brand A
    Aust N Z J Obstet Gynaecol; 2003 Dec; 43(6):414-20. PubMed ID: 14712943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraceptives and reproductive cancers: weighing the risks and benefits.
    Coker AL; Harlap S; Fortney JA
    Fam Plann Perspect; 1993; 25(1):17-21, 36. PubMed ID: 8432372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of female breast and genital cancer: analysis of the age-dependence.
    Dix D; Cohen P; Barzegar S
    Anticancer Res; 1983; 3(4):251-5. PubMed ID: 6881922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.